Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

TSXV:CLAS.H - Post Discussion

Claritas Pharmaceuticals Inc > Markets Closed Monday !!!
View:
Post by HighSkies2019 on Sep 03, 2021 12:02pm

Markets Closed Monday !!!

Long weekend ...phase 1 starts Sept 15 CM2620 on CMAX site ... if ours news has to come shortly .... either way we all know not much longer before we get something ....our GVHD is still in our hands ... our financial statements are current...balance sheets are in great shape...R107 to cover multiple markets in the billions ...GVHD...Pain med ...short cohorts then a buyer... or are we already taken....have a nice long week end ..... gltal
Comment by bud13 on Sep 03, 2021 12:59pm
</br /for the gvhd it's still hard to just give it away for the few mil owed on it after all we put in to it for the progress of it and get no recognition for the millions upon millions spent on it. so is the company now re thinking this?>
Comment by TheKneeH on Sep 03, 2021 3:16pm
Nope "...Claritas will transfer all assets of its program developing cannabidiol for the prevention and treatment of graft versus host disease (the “GVHD Program”) to the Talent Shareholders..." here: https://www.globenewswire.com/en/news-release/2021/06/01/2239359/0/en/Claritas-Announces-Transfer-of-GVHD-Program-and-Cancellation-of-Related-Debt-as-Company-Focuses-on-Nitric-Oxide ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities